洽洽食品(002557.SZ):擬出資2億元參投復星洽洽科技消費私募股權投資基金合夥企業
格隆匯12月9日丨洽洽食品(002557.SZ)公佈,為滿足公司戰略發展需要,公司擬以自有資金2億元與南京復星洽洽企業管理合夥企業(有限合夥)(以工商部門最終核定為準)、上海復星高科技(集團)有限公司、合肥華泰集團股份有限公司、安徽安聯投資諮詢有限公司、共青城星洽投資合夥企業(有限合夥)共同投資設立復星洽洽科技消費私募股權投資基金合夥企業(有限合夥)(以工商部門最終核定為準),基金目標規模為人民幣5億元。
該基金通過對消費及科技領域項目進行適用法律及經營範圍所允許的參股為主的股權及股權相關投資,實現資本增值。其中該基金針對食品飲料消費領域項目的投資金額不低於人民幣1億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.